Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...

Bladder cancer patients given an immunotherapy drug ... Patients were given either standard chemotherapy (cisplatin and gemcitabine) and surgery (530 people), or chemotherapy plus durvalumab ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

They were used on five patients, and four of them are now either in remission or cancer-free. Read more at straitstimes.com.

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...

A “game-changer” study claims bladder cancer patients given an immunotherapy ... chemotherapy (cisplatin and gemcitabine) and surgery (530 people), or chemotherapy plus durvalumab before ...